Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2025 Filed Jan 7, 2025 22:27 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionCommon Stock | 17,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 3 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 6 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,090 Underlying: Common Stock · 5,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Tax withholdingCommon Stock | 2,217 | $15.30 | $33,920.10 |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,003 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 6 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,490 Underlying: Common Stock · 5,245 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,054 | $15.30 | $31,426.20 |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 4 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,802 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 5,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:33 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001046 · form4-01072025_100117.xml · derivative · entry 5 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,665 Underlying: Common Stock · 10,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:33 UTC |
Lizzul Paul F.Chief Medical Officer
|
Tax withholdingCommon Stock | 4,336 | $14.60 | $63,305.60 |
DisclosureSEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,759 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:33 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 10,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 142 shares acquired under the Company's ESPP. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:27 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 34,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001034 · form4-01072025_100123.xml · derivative · entry 5 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,032 Underlying: Common Stock · 34,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:27 UTC |
Faga DanielDirector · President, CEO
|
Tax withholdingCommon Stock | 13,033 | $14.60 | $190,281.80 |
DisclosureSEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 2 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 425,003 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:27 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionCommon Stock | 34,678 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 1 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 212 shares acquired under the Company's ESPP. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 5 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,862 Underlying: Common Stock · 7,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Tax withholdingCommon Stock | 2,994 | $14.60 | $43,712.40 |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,675 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 17:32 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 7,288 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 141 shares acquired under the Company's ESPP. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 5 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,877 Underlying: Common Stock · 8,293 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 3,407 | $14.60 | $49,742.20 |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,611 F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:32 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 8,293 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 981 shares acquired under the Company's ESPP. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 18:17 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 6,646 | $12.95 | $86,069.69 |
DisclosureSEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 7,880,094 F7 · shares: Qualified Fund purchased all of the securities in this transaction. F8 · balance_after: After this transaction, Qualified Fund held 7,401,972 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 18:17 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 13,268 | $12.93 | $171,512.78 |
DisclosureSEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 7,873,448 F5 · shares: Qualified Fund purchased all of the securities in this transaction. F6 · balance_after: After this transaction, Qualified Fund held 7,395,326 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 18:17 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 65,184 | $12.92 | $842,059.95 |
DisclosureSEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 7,860,180 F2 · shares: Qualified Fund purchased all of the securities in this transaction. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.71 to $12.9552, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 3. F4 · balance_after: After this transaction, Qualified Fund held 7,382,058 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:35 UTC |
RENTON HOLLINGSDirector
|
Exercise / conversionCommon Stock · Derivative | 10,000 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001415889-24-028094 · form4-12032024_091237.xml · derivative · entry 3 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,925 Underlying: Common Stock · 10,000 shares Expires 2025-07-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025. F3 · balance_after: In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 95,541 shares of common stock, which options vest according to their terms. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:35 UTC |
RENTON HOLLINGSDirector
|
SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001415889-24-028094 · form4-12032024_091237.xml · nonDerivative · entry 2 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,950 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:35 UTC |
RENTON HOLLINGSDirector
|
Exercise / conversionCommon Stock | 10,000 | $6.93 | $69,300.00 |
DisclosureSEC source: 0001415889-24-028094 · form4-12032024_091237.xml · nonDerivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:18 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon · Derivative | 1,500 | $0.00 Strike: $18.50 | $0.00 |
DisclosureSEC source: 0001415889-24-023900 · form4-09242024_080920.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,000 Underlying: Common · 1,500 shares Expires 2030-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F3 · balance_after: In addition to the remaining options to purchase 85,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:18 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 1,500 | $38.67 | $58,005.00 |
DisclosureSEC source: 0001415889-24-023900 · form4-09242024_080920.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,398 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2024. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:18 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $18.50 | $27,750.00 |
DisclosureSEC source: 0001415889-24-023900 · form4-09242024_080920.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 3,780 | $38.41 | $145,190.93 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 5 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,240 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:42 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 2,220 | $38.93 | $86,424.60 |
DisclosureSEC source: 0001415889-24-023550 · form4-09172024_100907.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,398 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · derivative · entry 7 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,000 Underlying: Common Stock · 5,000 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F8 · balance_after: In addition to the remaining options to purchase 73,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 6,500 | $40.13 | $260,845.00 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,020 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $14.02 | $70,100.00 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,220 | $38.93 | $86,424.60 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,520 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $20.16 | $0.00 |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · derivative · entry 6 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,600 Underlying: Common Stock · 10,000 shares Expires 2030-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F6 · balance_after: In addition to the remaining options to purchase 80,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 263,040 shares of common stock, which options vest according to their terms. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 10,000 | $40.13 | $401,300.00 |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 4 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,744 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 14, 2024. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $20.16 | $201,600.00 |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,220 | $38.93 | $86,424.60 |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,744 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 22:45 UTC |
Orwin John ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023552 · form4-09172024_100957.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 1,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. F2 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 22:45 UTC |
Orwin John ADirector
|
Exercise / conversionCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023552 · form4-09172024_100957.xml · nonDerivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 22:42 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023550 · form4-09172024_100907.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 22:42 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-023550 · form4-09172024_100907.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · derivative · entry 6 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F6 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 18:44 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Includes 1,500 shares acquired under the Employee Stock Purchase Plan as of May 15, 2024. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · derivative · entry 5 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 22:41 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:09 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon · Derivative | 2,000 | $0.00 Strike: $18.50 | $0.00 |
DisclosureSEC source: 0001415889-24-021452 · form4-08162024_080835.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,500 Underlying: Common · 2,000 shares Expires 2030-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F3 · balance_after: In addition to the remaining options to purchase 86,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:09 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 2,000 | $40.00 | $80,000.00 |
DisclosureSEC source: 0001415889-24-021452 · form4-08162024_080835.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,618 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2023. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:09 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,000 | $18.50 | $37,000.00 |
DisclosureSEC source: 0001415889-24-021452 · form4-08162024_080835.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 16:04 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 273,972 | $36.50 | $9,999,978.00 |
DisclosureSEC source: 0000935836-24-000532 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 7,794,996 F2 · shares: Qualified Fund purchased all of the shares acquired in this transaction. F3 · balance_after: After this transaction, Qualified Fund holds 7,316,874 shares of Issuer's Common Stock. F1 · ownership.nature: The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund ("the Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold shares directly for the benefit of their investors. EcoR1 may be deemed to beneficially own the shares indirectly as the investment adviser to the Fund, and Mr. Nodelman may be deemed to beneficially own them indirectly as the control person of EcoR1. The filers disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.